<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-U02-FLZM8</udiDi>
    <basicUdiDi>B-U02-FLZM8</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test -7-Aminoflunitrazepam (FLZ)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-FLZ</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.503Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-FYLMK</udiDi>
    <basicUdiDi>B-U02-FYLMK</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Fentanyl (FYL)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-FYL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.434Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-GABJU</udiDi>
    <basicUdiDi>B-U02-GABJU</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Gabapentin (GAB)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-GAB</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.399Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-HMOLX</udiDi>
    <basicUdiDi>B-U02-HMOLX</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test -Hydromorphone (HMO)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-HMO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.369Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-KETLY</udiDi>
    <basicUdiDi>B-U02-KETLY</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Ketamine (KET)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-KET</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.327Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-KRALZ</udiDi>
    <basicUdiDi>B-U02-KRALZ</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Kratom (KRA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-KRA</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.260Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-LSDMF</udiDi>
    <basicUdiDi>B-U02-LSDMF</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Lysergic Acid Diethylamide (LSD)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-LSD</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.226Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-MCAT3A</udiDi>
    <basicUdiDi>B-U02-MCAT3A</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Methcathinone (MCAT)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-MCAT</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.180Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U02-MDMA3D</udiDi>
    <basicUdiDi>B-U02-MDMA3D</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Ecstasy (MDMA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U02-MDMA</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.153Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-6MAMYB</udiDi>
    <basicUdiDi>B-U04-6MAMYB</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - 6-Monoacetylmorphine (6-MAM)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-6MAM</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.120Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-FLZMW</udiDi>
    <basicUdiDi>B-U04-FLZMW</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test -7-Aminoflunitrazepam (FLZ)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-FLZ</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.081Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-FYLN9</udiDi>
    <basicUdiDi>B-U04-FYLN9</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Fentanyl (FYL)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-FYL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:35.009Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-GABKJ</udiDi>
    <basicUdiDi>B-U04-GABKJ</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Gabapentin (GAB)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-GAB</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:34.980Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-HMOMM</udiDi>
    <basicUdiDi>B-U04-HMOMM</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test -Hydromorphone (HMO)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-HMO</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:34.952Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-KETMN</udiDi>
    <basicUdiDi>B-U04-KETMN</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Ketamine (KET)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-KET</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:27.163Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-KRAMP</udiDi>
    <basicUdiDi>B-U04-KRAMP</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Kratom (KRA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-KRA</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:27.122Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-LSDN5</udiDi>
    <basicUdiDi>B-U04-LSDN5</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Lysergic Acid Diethylamide (LSD)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-LSD</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:27.069Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-MCAT44</udiDi>
    <basicUdiDi>B-U04-MCAT44</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Methcathinone (MCAT)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-MCAT</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:27.035Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U04-MDMA47</udiDi>
    <basicUdiDi>B-U04-MDMA47</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Ecstasy (MDMA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U04-MDMA</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:27.003Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-U01-MDAKN</udiDi>
    <basicUdiDi>B-U01-MDAKN</basicUdiDi>
    <tradeName>Single-Drug Drug of Abuse Test - Tenamfetamine (MDA)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Aceso Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000045175</manufacturerSrn>
    <authorisedRepresentativeName>VidaQuick Biotech S.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000048138</authorisedRepresentativeSrn>
    <riskClass>IVD Genel</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>U01-MDA</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T18:20:25.647Z</lastUpdated>
  </row>
</eudamedExport>